Application

16295914 · COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT

Filed 2019-03-07 · Abandoned The official file ↗ · Art unit 1627 · Examiner Sreenivasan Padmanabhan Hard · CPC A61K 31/13 · Adamas Pharma, LLC · Cooley LLP/Adamas Pharma, LLC

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.7 mo

to disposition 9.1 mo

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.